Li Bin

10% owner at Sorrento Therapeutics, Inc. · on record since Jul 15, 2016
Director at China Marketing Media Holdings, Inc. · on record since Apr 12, 2007
10% owner at CHINA VALVES TECHNOLOGY, INC · on record since Apr 18, 2008
10% owner at China Senior Living Industry International Holding Corp · on record since Jul 11, 2011
Former 10% owner at CHINA VALVES TECHNOLOGY, INC · on record since Sep 19, 2012
10% owner at BIOCLINICA INC · on record since Oct 24, 2016
See Remarks at SCICLONE PHARMACEUTICALS INC · on record since Mar 1, 2016
Director at Cogo Group Inc. · on record since Jan 12, 2005
Chief Product Officer at Philip Morris International Inc. · on record since Aug 7, 2019
Director at Xtraplan, Inc. · on record since Jul 22, 2005

Insider trading activity of Li Bin

Figures computed from official regulatory filings — .

Insufficient history for a statistical track record (fewer than 5 open-market buys).

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Philip Morris International Inc.Listing on record	Apr 1, 2021	Award	6,010	83.81 USD	$503.7K	SEC
Philip Morris International Inc.Listing on record	Feb 8, 2021	Award	6,290	81.86 USD	$514.9K	SEC
Philip Morris International Inc.Listing on record	Feb 10, 2020	Award	5,500	86.69 USD	$476.8K	SEC
CHINA VALVES TECHNOLOGY, INCListing unverified	Sep 19, 2012	Other	-12,583,032	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Philip Morris International Inc.Listing on record	Apr 1, 2021	Award	6,010	83.81 USD	$503.7K	SEC
Philip Morris International Inc.Listing on record	Feb 8, 2021	Award	6,290	81.86 USD	$514.9K	SEC
Philip Morris International Inc.Listing on record	Feb 10, 2020	Award	5,500	86.69 USD	$476.8K	SEC
CHINA VALVES TECHNOLOGY, INCListing unverified	Sep 19, 2012	Other	-12,583,032	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC